Rubicon Research Ltd — promoter holding and stake value
Pharmaceuticals & Biotechnology
The promoter group of Rubicon Research Ltd holds 59.76% of the company. At a market capitalisation of ₹28.43k cr, that holding is worth ₹16.99k cr.
Promoter stake
59.76%
Value of holding
₹16.99k cr
Market cap
₹28.43k cr
Stake change
-8.74%
Promoter stake, quarter by quarter
| Quarter | Holding | Stake % | Pledged |
|---|---|---|---|
| Q4-2025 | 59.99% | — | |
| Q1-2026 | 59.86% | — | |
| Q2-2026 | 59.76% | — | |
| Q3-2026 | 51.25% | — |
Promoter holdings in Pharmaceuticals & Biotechnology
- Sun Pharmaceutical Industries52.68%₹2.24 lakh cr
- Divis Laboratories51.87%₹1.39 lakh cr
- Torrent Pharmaceuticals60.78%₹1.08 lakh cr
- Zydus Lifesciences75.01%₹92.83k cr
- Mankind Pharma72.62%₹74.24k cr
- Aurobindo Pharma51.88%₹50.58k cr
What this figure is, and is not
The value shown is Rubicon Research Ltd's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.
A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.